Independent Director · Verve Therapeutics, Inc. (VERV)

Chair, Audit Committee

Michael MacLean director compensation at Verve Therapeutics: $534K

Fiscal year 2024 director compensation for Michael MacLean at Verve Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 25, 2025 (DEF 14A). Open the filing on EDGAR.

Free

Get Michael MacLean’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Michael MacLean and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Verve Therapeutics Director Compensation Table · all 3 fiscal years held
In US dollars, as Verve Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2024$65,000$0$468,999$0$533,999
FY2023$55,000—$466,070—$521,070
FY2022$50,000—$148,907—$198,907

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Verve Therapeutics, Inc. DEF 14A filed April 25, 2025, accession 0000950170-25-058325, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Verve Therapeutics, Inc. filed document, accession 0000950170-25-058325. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2025.

Get the Verve Therapeutics Board Governance Report

$533,999 Michael MacLean, FY2024 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 25, 2025 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2024

Verve Therapeutics pays directors a $45,000 cash retainer and $170,000 in Options.

Committees

FY2024 · as the proxy prints them

Audit (Chair)

The rest of the Verve Therapeutics board

FY2024 · as the company reported each
DirectorRoleFY2024 total
Alexander CumboIndependent Director$521,499
Burt Adelman, M.DChair of the Board$568,999
Jodie MorrisonIndependent Director$964,970
Krishna Yeshwant, M.DIndependent Director$522,667
Lonnel CoatsIndependent Director$521,499
Ourania Tatsis, Ph.DDirector—
Sekar Kathiresan, M.DDirector—
Sheila Mikhail, J.DIndependent Director$526,499

The full Verve Therapeutics compensation record

free company brief

This page is one director within Verve Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order VERV

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report